NASDAQ:ALEC - Alector Stock Price, Forecast & News

Alector trades on the NASDAQ under the ticker symbol "ALEC."

Alector Inc (NASDAQ:ALEC) released its earnings results on Tuesday, November, 12th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.40) by $0.07. The company earned $2.70 million during the quarter. Alector had a negative net margin of 378.57% and a negative return on equity of 58.27%. View Alector's Earnings History.

Alector is scheduled to release their next quarterly earnings announcement on Tuesday, March 24th 2020. View Earnings Estimates for Alector.

7 analysts have issued 1-year price objectives for Alector's stock. Their forecasts range from $26.00 to $28.00. On average, they expect Alector's stock price to reach $27.00 in the next twelve months. This suggests a possible upside of 22.7% from the stock's current price. View Analyst Price Targets for Alector.

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alector in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Alector.

Press coverage about ALEC stock has been trending positive on Tuesday, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Alector earned a daily sentiment score of 2.2 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Alector.

Alector saw a increase in short interest in December. As of December 31st, there was short interest totalling 4,280,000 shares, an increase of 19.2% from the December 15th total of 3,590,000 shares. Based on an average trading volume of 342,900 shares, the days-to-cover ratio is presently 12.5 days. Currently, 10.5% of the company's shares are sold short. View Alector's Current Options Chain.

Some companies that are related to Alector include argenx (ARGX), bluebird bio (BLUE), Repligen (RGEN), China Biologic Products (CBPO), Spark Therapeutics (ONCE), Ablynx (ABLYF), Adaptive Biotechnologies (ADPT), Crispr Therapeutics (CRSP), Allogene Therapeutics (ALLO), Momenta Pharmaceuticals (MNTA), Iovance Biotherapeutics (IOVA), Acceleron Pharma (XLRN), Halozyme Therapeutics (HALO), Audentes Therapeutics (BOLD) and Denali Therapeutics (DNLI).

Based on aggregate information from My MarketBeat watchlists, some companies that other Alector investors own include Editas Medicine (EDIT), Verizon Communications (VZ), Cisco Systems (CSCO), Exxon Mobil (XOM), Alibaba Group (BABA), Johnson & Johnson (JNJ), AT&T (T), CVS Health (CVS), Altria Group (MO) and Precision BioSciences (DTIL).

(ALEC) raised $177 million in an initial public offering (IPO) on Thursday, February 7th 2019. The company issued 9,300,000 shares at $18.00-$20.00 per share. Morgan Stanley, BofA Merrill Lynch, Cowen and Barclays acted as the underwriters for the IPO.

Alector's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Alpine Global Management LLC (0.04%). Company insiders that own Alector stock include Calvin Yu, Orbimed Advisors Llc, Robert King, Robert Paul and Sabah Oney. View Institutional Ownership Trends for Alector.

ALEC stock was acquired by a variety of institutional investors in the last quarter, including Alpine Global Management LLC. View Insider Buying and Selling for Alector.

Shares of ALEC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of ALEC stock can currently be purchased for approximately $22.00.

Alector has a market capitalization of $1.52 billion and generates $27.51 million in revenue each year. The company earns $-52,250,000.00 in net income (profit) each year or ($4.62) on an earnings per share basis. Alector employs 91 workers across the globe.View Additional Information About Alector.

The official website for Alector is http://www.alector.com/.

Alector's mailing address is 151 OYSTER POINT BLVD. SUITE 300, SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 415-231-5660 or via email at [email protected]